Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
caly-002 (1 trial)
Celiac Disease (Phase 1)
Eosinophilic Esophagitis (Phase 1)
Esophagitis (Phase 1)
Trials (1 total)
Trial APIs (1 total)